The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Galectin expression in cancer diagnosis and prognosis: A systematic review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598
Galectins. Structure and function of a large family of animal lectins.
Barondes, S. H., Cooper, D. N., Gitt, M. A., & Leffler, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31891-4 · Cited by 1,496
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Galectins: A family of animal β-galactoside-binding lectins
Barondes, S. H., Castronovo, V., Cooper, D. N. W., Cummings, R. D., Drickamer, K., Felzi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., Kasai, K.-I., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90498-7 · Cited by 1,223
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,013
Galectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Intracellular functions of galectins
Liu, F. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00313-6 · Cited by 675
Rubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A., Ilarregui, J. M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O. L., & Rabinovich, G. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00024-8 · Cited by 531
Ahmad, N., Gabius, H.-J., André, S., Kaltner, H., Sabesan, S., Roy, R., Liu, B., Macaluso, F., & Brewer, C. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312834200 · Cited by 517
Croci, D. O., Cerliani, J. P., Dalotto-Moreno, T., Méndez-Huergo, S. P., Mascanfroni, I. D., Dergan-Dylon, S., Toscano, M. A., Caramelo, J. J., García-Vallejo, J. J., Ouyang, J., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.043 · Cited by 505
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
Thijssen, V. L. J. L., Postel, R., Brandwijk, R. J. M. G. E., Dings, R. P. M., Nesmelova, I., Satijn, S., Verhofstad, N., Nakabeppu, Y., Baum, L. G., Bakkers, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603883103 · Cited by 497
Self-citationAdamczyk, B., Tharmalingam, T., & Rudd, P. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.001 · Cited by 478
Bartolazzi, A., Gasbarri, A., Papotti, M., Bussolati, G., Lucante, T., Khan, A., Inohara, H., Marandino, F., Orlandi, F., Nardi, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04817-0 · Cited by 409
Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation
Paz, A., Haklai, R., Elad-Sfadia, G., Ballan, E., & Kloog, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204950 · Cited by 400
Galectin-3 – A jack-of-all-trades in cancer
Newlaczyl, A. U., & Yu, L.-G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.003 · Cited by 362
Danguy, A. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00315-x · Cited by 343
Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
Rabinovich, G. A., & Croci, D. O. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.004 · Cited by 338
Shen, J., Person, M. D., Zhu, J., Abbruzzese, J. L., & Li, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3262 · Cited by 337
Xu, X., El‐Naggar, A. K., & Lotan, R. (1995) · Europe PMC (PubMed Central) · Cited by 332
Pienta, K. J., Nailk, H., Akhtar, A., Yamazaki, K., Replogle, T. S., Lehr, J., Donat, T. L., Tait, L., Hogan, V., & Raz, A. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.5.348 · Cited by 272
Dalotto-Moreno, T., Croci, D. O., Cerliani, J. P., Martinez-Allo, V. C., Dergan-Dylon, S., Méndez-Huergo, S. P., Stupirski, J. C., Mazal, D., Osinaga, E., Toscano, M. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2418 · Cited by 261
Galectin-1: A Link Between Tumor Hypoxia and Tumor Immune Privilege
Le, Q.-T., Shi, G., Cao, H., Nelson, D. W., Wang, Y., Chen, E. Y., Zhao, S., Kong, C., Richardson, D., O'Byrne, K. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0206 · Cited by 258
Türeci, Ö., Schmitt, H., Fadle, N., Pfreundschuh, M., & Sahin, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6416 · Cited by 255
Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
Thijssen, V. L., Barkan, B., Shoji, H., Aries, I. M., Mathieu, V., Deltour, L., Hackeng, T. M., Kiss, R., Kloog, Y., Poirier, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4150 · Cited by 244
Self-citationLotz, M. M., Andrews, C. W., Korzelius, C. A., Lee, E. C., Steele, G. D., Clarke, A., & Mercurio, A. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3466 · Cited by 230
Identification and characterization of genes associated with human hepatocellular carcinogenesis.
Kondoh, N., Wakatsuki, T., Ryo, A., Hada, A., Aihara, T., Horiuchi, S., Goseki, N., Matsubara, O., Takenaka, K., Shichita, M., et al. (1999) · PubMed · Cited by 229
Terris, B., Blaveri, E., Crnogorac-Jurcevic, T., Jones, M., Missiaglia, E., Ruszniewski, P., Sauvanet, A., & Lemoine, N. R. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61121-2 · Cited by 225
Galectin-9 as a Prognostic Factor with Antimetastatic Potential in Breast Cancer
Irie, A., Yamauchi, A., Kontani, K., Kihara, M., Liu, D., Shirato, Y., Seki, M., Nishi, N., Nakamura, T., Yokomise, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0861 · Cited by 207
Kageshita, T., Kashio, Y., Yamauchi, A., Seki, M., Abedin, M. J., Nishi, N., Shoji, H., Nakamura, T., Ono, T., & Hirashima, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10436 · Cited by 198
Croci, D. O., Salatino, M., Rubinstein, N., Cerliani, J. P., Cavallin, L. E., Leung, H. J., Ouyang, J., Ilarregui, J. M., Toscano, M. A., Domaica, C. I., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111665 · Cited by 196
Galectins-1 and -3 and their ligands in tumor biology
André, S., Kojima, S., Yamazaki, N., Fink, C., Kaltner, H., Kayser, K., & Gabius, H.-J. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050303 · Cited by 182
Barrow, H., Guo, X., Wandall, H. H., Pedersen, J. W., Fu, B., Zhao, Q., Chen, C., Rhodes, J. M., & Yu, L.-G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1462 · Cited by 181
van den Brûle, F., Califice, S., Garnier, F., Fernandez, P. L., Berchuck, A., & Castronovo, V. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000059949.01480.40 · Cited by 176
The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.
Gong, H. C., Honjo, Y., Nangia‐Makker, P., Hogan, V. A., Mazurak, N., Bresalier, R. S., & Raz, A. (1999) · PubMed · Cited by 175
Camby, I., Belot, N., Rorive, S., Lefranc, F., Maurage, C., Lahm, H., Kaltner, H., Hadari, Y., Ruchoux, M., Brotchi, J., et al. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00377.x · Cited by 172
Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
Jiang, J., Jin, M.-S., Kong, F., Cao, D., Ma, H.-X., Jia, Z., Wang, Y.-P., Suo, J., & Cao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081799 · Cited by 172
Glinskii, O. V., Huxley, V. H., Glinsky, G. V., Pienta, K. J., Raz, A., & Glinsky, V. V. (2005) · Neoplasia · doi:10.1593/neo.04646 · Cited by 170
Laderach, D. J., Gentilini, L. D., Giribaldi, L., Delgado, V. C., Nugnes, L., Croci, D. O., Al Nakouzi, N., Sacca, P., Casas, G., Mazza, O., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1260 · Cited by 170
Jung, E., Moon, H., Cho, B. I., Jeong, C., Joo, Y., Lee, Y., Hong, S., Choi, S., Ha, W., Kim, J. W., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22434 · Cited by 166
Tang, D., Yuan, Z., Xue, X., Lu, Z., Zhang, Y., Wang, H., Chen, M., An, Y., Wei, J., Zhu, Y., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26290 · Cited by 162
Wu, M., Hong, H.-C., Hong, T.-M., Chiang, W.-F., Jin, Y., & Chen, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1824 · Cited by 151
Identification of tumor‐associated proteins in oral tongue squamous cell carcinoma by proteomics
He, Q., Chen, J., Kung, H., et al. (2004) · PROTEOMICS · doi:10.1002/pmic.200300550 · Cited by 149
Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
Banh, A., Zhang, J., Cao, H., Bouley, D. M., Kwok, S., Kong, C. S., Giaccia, A. J., Koong, A. C., & Le, Q. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4157 · Cited by 133
Comparative Analysis of Galectins in Primary Tumors and Tumor Metastasis in Human Pancreatic Cancer
Berberat, P. O., Frieß, H., Wang, L., Zhu, Z., Bley, T. A., Frigeri, L. G., Zimmermann, A., & Büchler, M. W. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900414 · Cited by 131
Song, S., Ji, B., Ramachandran, V., Wang, H., Hafley, M., Logsdon, C. D., & Bresalier, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042699 · Cited by 131
John, C. M., Leffler, H., Kahl‐Knutsson, B., Svensson, I., & Jarvis, G. A. (2003) · PubMed · Cited by 130
Nagy, N. A., Bronckart, Y., Camby, I., Legendre, H., Lahm, H., Kaltner, H., Hadari, Y., Ham, P. V., Yeaton, P., Pector, J.-C., et al. (2002) · Gut · doi:10.1136/gut.50.3.392 · Cited by 130
A distinct molecular profile associated with mucinous epithelial ovarian cancer
Heinzelmann-Schwarz, V. A., Gardiner‐Garden, M., Henshall, S. M., Scurry, J., Scolyer, R. A., Smith, A. N., Bali, A., Bergh, P. M. V., Baron-Hay, S. E., Scott, C. D., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603003 · Cited by 128
Saussez, S., Lorfevre, F., Lequeux, T., Laurent, G., Chantrain, G., Vertongen, F., Toubeau, G., Decaestecker, C., & Robert Kiss, A. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2006.12.014 · Cited by 125
Galectin-9 in tumor biology: A jack of multiple trades
Heusschen, R., Griffioen, A. W., & Thijssen, V. L. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.04.006 · Cited by 123
Self-citationRegulation of Prostate Cancer Progression by Galectin-3
Wang, Y., Nangia‐Makker, P., Tait, L. R., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080816 · Cited by 122
Matos, L. L., del Giglio, A. B., Matsubayashi, C. O., Farah, M. D. L., del Giglio, A., & Pinhal, M. A. D. S. (2012) · Diagnostic Pathology · doi:10.1186/1746-1596-7-97 · Cited by 122
Galectin‐4 functions as a tumor suppressor of human colorectal cancer
Satelli, A., Rao, P. S., Thirumala, S. D., & Rao, U. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25750 · Cited by 120
Merlin, J., Stechly, L., de Beauce, S., Monté, D., Leteurtre, E., SEUNINGEN, I. V., Huet, G., & Pigny, P. (2011) · Oncogene · doi:10.1038/onc.2010.631 · Cited by 116
Martínez‐Bosch, N., Fernández‐Barrena, M. G., Moreno, M., Zapater, E. O., Munné‐Collado, J., Iglesias, M., André, S., Gabius, H., Hwang, R. F., Poirier, F., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3013 · Cited by 115
Marchetti, A., Tinari, N., Buttitta, F., Chella, A., Angeletti, C. A., Sacco, R., Mucilli, F., Ullrich, A., & Iacobelli, S. (2002) · PubMed · Cited by 114
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model
Liu, H., Huang, Z., Yang, G., Lu, W., & Yu, N. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.7386 · Cited by 113
Cleavage of galectin‐3 by matrix metalloproteases induces angiogenesis in breast cancer
Nangia‐Makker, P., Wang, Y., Raz, T., Tait, L. R., Balan, V., Hogan, V. A., & Raz, A. (2010) · International Journal of Cancer · doi:10.1002/ijc.25254 · Cited by 112
Chen, C., Duckworth, C. A., Zhao, Q., Pritchard, D. M., Rhodes, J. M., & Yu, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2940 · Cited by 110
Galectin-3 inhibitors: a patent review (2008–present)
Blanchard, H., Yu, X., Collins, P. M., & Bum‐Erdene, K. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.947961 · Cited by 108
Mac‐2‐binding protein is a diagnostic marker for biliary tract carcinoma
Koopmann, J., Thuluvath, P. J., ZAHURAK, M. L., Kristiansen, T. Z., Pandey, A., Schulick, R. D., Argani, P., Hidalgo, M. M., Iacobelli, S., Goggins, M., et al. (2004) · Cancer · doi:10.1002/cncr.20469 · Cited by 106
Zhang, P., Zhang, P., Shi, B., Zhou, M., Jiang, H., Zhang, H., Pan, X., Gao, H., Sun, H., & Li, Z. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.526 · Cited by 105
Clark, M. C., Pang, M., Hsu, D. K., Liu, F., de Vos, S., Gascoyne, R. D., SAID, J. W., & Baum, L. G. (2012) · Blood · doi:10.1182/blood-2012-06-438234 · Cited by 101
Kuo, P.-L., Hung, J., Huang, S.-K., Chou, S., Cheng, D.-E., Jong, Y., Hung, C., Yang, C., Tsai, Y., Hsu, Y.-L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002940 · Cited by 98
Yamamoto‐Sugitani, M., Kuroda, J., Ashihara, E., Nagoshi, H., Kobayashi, T., Matsumoto, Y., Sasaki, N., Shimura, Y., Kiyota, M., Nakayama, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111138108 · Cited by 97
Clausse, N., van den Brûle, F., Waltregny, D., Garnier, F., & Castronovo, V. (1999) · Angiogenesis · doi:10.1023/a:1026584523789 · Cited by 93
Cedeno‐Laurent, F., Watanabe, R., Teague, J. E., Kupper, T. S., Clark, R. A., & Dimitroff, C. J. (2012) · Blood · doi:10.1182/blood-2011-12-396457 · Cited by 92
Vascular galectins: Regulators of tumor progression and targets for cancer therapy
Thijssen, V. L., Rabinovich, G. A., & Griffioen, A. W. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.07.003 · Cited by 89
Self-citationPrognostic Significance of Endogenous Adhesion/Growth-Regulatory Lectins in Lung Cancer
Szőke, T., Kayser, K., Baumhäkel, J.-D., Troján, I., Furák, J., Tiszlavicz, L., Horvath, A., Szluha, K., Gabius, H., & André, S. (2005) · Oncology · doi:10.1159/000087841 · Cited by 88
Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma.
Konstantinov, K. N., Robbins, B. A., & Liu, F. T. (1996) · Europe PMC (PubMed Central) · Cited by 87
Langbein, S., Brade, J., Badawi, J. K., Hatzinger, M., Kaltner, H., Lensch, M., Specht, K., André, S., Brinck, U., Alken, P. M., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02852.x · Cited by 85
Rechreche, H., Mallo, G. V., Montalto, G., Dagorn, J., & Iovanna, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00225.x · Cited by 84
Ouyang, J., Plütschow, A., von Strandmann, E. P., Reiners, K. S., Ponader, S., Rabinovich, G. A., Neuberg, D. S., Engert, A., & Shipp, M. A. (2013) · Blood · doi:10.1182/blood-2012-12-474569 · Cited by 82
Inhibition of Galectins with Small Molecules
Öberg, C. T., Leffler, H., & Nilsson, U. J. (2011) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2011.18 · Cited by 79
High serum galectin-3 in advanced melanoma: preliminary results.
Vereecken, P. M., Boudjeltia, K. Z., Debray, C., Awada, A. H., Legssyer, I., Salès, F., Pétein, M., Vanhaeverbeek, M., Ghanem, G., & Heenen, M. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01992.x · Cited by 77
Galectins as Cancer Biomarkers
Balan, V., Nangia‐Makker, P., & Raz, A. (2010) · Cancers · doi:10.3390/cancers2020592 · Cited by 77
Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness
Spano, D., Russo, R., Maso, V. D., Rosso, N., Terracciano, L., Roncalli, M. G., Tornillo, L., Capasso, M., Tiribelli, C., & Iolascon, A. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00119 · Cited by 76
Ito, K., & Ralph, S. J. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9471-7 · Cited by 75
Chiang, W.-F., Liu, S.-Y., Fang, L.-Y., Lin, C.-N., Wu, M., Chen, Y.-C., Chen, Y.-L., & Jin, Y. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.03.004 · Cited by 74
Galectin-3 – an emerging prognostic indicator in advanced head and neck carcinoma
Plzák, J., Betka, J., Smetana, K., Chovanec, M., Kaltner, H., André, S., Kodet, R., & Gabius, H. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.06.025 · Cited by 74
Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer
Kim, S. W., Park, K. C., Jeon, S. M., Ohn, T. B., Kim, T. I., Kim, W. H., & Cheon, J. H. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0124-x · Cited by 72
Serum level of galectin-3 in human bladder cancer
Sakaki, M., Oka, N., Nakanishi, R., Yamaguchi, K., Fukumori, T., & Kanayama, H. (2008) · The Journal of Medical Investigation · doi:10.2152/jmi.55.127 · Cited by 71
Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma
Liang, M., Ueno, M., Oomizu, S., Arikawa, T., Shinonaga, R., Zhang, S., Yamauchi, A., & Hirashima, M. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0352-z · Cited by 70
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Galectin-1 in Melanoma Biology and Related Neo-Angiogenesis Processes
Mathieu, V., de Lassale, E. M., Toelen, J., Mohr, T. T., Bellahcène, A., Goietsenoven, G. V., Verschuere, T., Bouzin, C., Debyser, Z., Vleeschouwer, S. D., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.142 · Cited by 68
Chiariotti, L., Berlingieri, M. T., Battaglia, C., Benvenuto, G., Martelli, M. L., Salvatore, P., Chiappettaxy, G., Bruni, C. B., & Fusco, A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640305 · Cited by 67
Baldus, S. E., Zirbes, T. K., Weingarten, M., Fromm, S., Glossmann, J.-P., Hanisch, F., ̈nig, S. P. M., der, W. S. X. F., Flucke, U., Thiele, J., et al. (2000) · Tumor Biology · doi:10.1159/000030131 · Cited by 67
Mirandola, L., Yu, Y., Chui, K. K., Jenkins, M., Cobos, E., John, C. M., & Chiriva‐Internati, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021811 · Cited by 66
White, N. M. A., Masui, O., Newsted, D., Scorilas, A., Romaschin, A. D., Bjarnason, G. A., Siu, K. W. M., & Yousef, G. M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.828 · Cited by 66
Galectin 9 is the sugar-regulated urate transporter/channel UAT
Lipkowitz, M. S., Leal-Pinto, E., Cohen, B. E., & Abramson, R. G. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014078.65610.2f · Cited by 65
Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
Okada, K., Shimura, T., Suehiro, T., Mochiki, E., & Kuwano, H. (2006) · PubMed · Cited by 65
Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.
Shimamura, T., Sakamoto, M., Ino, Y., Shimada, K., Kosuge, T., Sato, Y., Tanaka, K., Sekihara, H., & Hirohashi, S. (2002) · PubMed · Cited by 62
Chen, R., Pan, S., Ottenhof, N. A., de Wilde, R. F., Wolfgang, C. L., Lane, Z., Post, J., Bronner, M. P., Willmann, J. K., Maitra, A., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20842 · Cited by 62
Balan, V., Nangia‐Makker, P., Schwartz, A. G., Jung, Y. S., Tait, L. R., Hogan, V. A., Raz, T., Wang, Y., Yang, Z. Q., Wu, G. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-3224 · Cited by 62
Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression
Lotan, R., Matsushita, Y., Ohannesian, D. W., Carralero, D., Ota, D. M., Cleary, K. R., Nicolson, G. L., & Irimura, T. (1991) · Carbohydrate Research · doi:10.1016/s0008-6215(00)90597-4 · Cited by 61
Vereecken, P., Awada, A. H., Suciu, S., de Castro, G., Morandini, R., Lityń́ska, A., Líénard, D., Ezzedine, K., Ghanem, G., & Heenen, M. (2009) · Melanoma Research · doi:10.1097/cmr.0b013e32832ec001 · Cited by 61
Galectin-3: a possible complementary marker to the PSA blood test
Balan, V., Wang, Y., Nangia‐Makker, P., Kho, D., Bajaj, M., Smith, D. W., Heilbrun, L. K., Raz, A., & Heath, E. I. (2013) · Oncotarget · doi:10.18632/oncotarget.923 · Cited by 60
Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery
Righi, M., Manfredi, R., Farneti, G., Pasquini, E., & Cenacchi, V. (1996) · Head & Neck · doi:10.1002/(sici)1097-0347(199609/10)18:5 · Cited by 60
Galectins: Major Signaling Modulators Inside and Outside the Cell
Compagno, D., Jaworski, F. M., Gentilini, L. D., Contrufo, G., Perez, I., Elola, M. T., Pregi, N., Rabinovich, G. A., & Laderach, D. J. (2014) · Current Molecular Medicine · doi:10.2174/1566524014666140603101953 · Cited by 60
Quantitative proteomics investigation of pancreatic intraepithelial neoplasia
Pan, S., Chen, R., Reimel, B. A., Crispin, D. A., Mirzaei, H., Cooke, K., Coleman, J. F., Lane, Z., Bronner, M. P., Goodlett, D. R., et al. (2009) · Electrophoresis · doi:10.1002/elps.200800752 · Cited by 59
Saal, I., Nagy, N., Lensch, M., Löhr, M. J., Manning, J. C., Decaestecker, C., André, S., Robert Kiss, A., Salmon, I. J., & Gabius, H. (2005) · PubMed · doi:10.14670/hh-20.1191 · Cited by 58
Cheng, C., Hou, H., Lee, M.-C., Liu, C., Jhuang, J., Lai, Y.-J., Lin, C., Chen, H., Liu, F., Chou, W., et al. (2013) · Blood · doi:10.1182/blood-2012-07-443762 · Cited by 58
Gao, X., Liu, D., Fan, Y., Li, X., Xue, H., Ma, Y., Zhou, Y., & Tai, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052430 · Cited by 56
D’Haene, N., Maris, C., Sandras, F., Dehou, M. F., Remmelink, M., Decaestecker, C., & Salmon, I. J. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800304 · Cited by 54
Matsui, Y., Ueda, S., Watanabe, J., Kuwabara, I., Ogawa, O., & Nishiyama, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3283 · Cited by 54
Clinical significance of Galectin-3 in clear cell renal cell carcinoma
Sakaki, M., Fukumori, T., Fukawa, T., Elsamman, E., Avirmed, S., Nakatsuji, H., & Kanayama, H. (2010) · The Journal of Medical Investigation · doi:10.2152/jmi.57.152 · Cited by 53
White, N. M. A., Masui, O., Newsted, D., Scorilas, A., Romaschin, A. D., Bjarnason, G. A., Siu, K. W. M., & Yousef, G. M. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.441 · Cited by 52
Galectins in hematological malignancies
Giordano, M., Croci, D. O., & Rabinovich, G. A. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328362370f · Cited by 52
Demers, M., Biron-Pain, K., Hébert, J., Lamarre, A., Magnaldo, T., & St‐Pierre, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3891 · Cited by 52
Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors.
Elola, M. T., Ferragut, F., Delgado, V. M. C., Nugnes, L., Gentilini, L. D., Laderach, D. J., Troncoso, M. F., Compagno, D., Wolfenstein‐Todel, C., & Rabinovich, G. A. (2014) · PubMed · doi:10.14670/hh-29.1093 · Cited by 50
Wang, L.-P., Chen, S., Zhuang, S.-M., Li, H., & Song, M. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9603-7 · Cited by 50
Ågesen, T. H., Berg, M., Clancy, T., Thiis‐Evensen, E., Cekaite, L., Lind, G. E., Nesland, J. M., Bakka, A. O., Mala, T., Hauss, H. J., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.43 · Cited by 50
Identification of Galectin-3 and Mucin-Type O-Glycans in Breast Cancer and Its Metastasis to Brain
Mayoral, M. Á., Mayoral, C., Meneses, A., Villalvazo, L., Guzman, A., Espinosa, B., Ochoa, J. L., Zenteno, E., & Guevara, J. (2008) · Cancer Investigation · doi:10.1080/07357900701837051 · Cited by 49
Mathieu, A., Saal, I., Vuckovic, A., et al. (2005) · Modern Pathology · doi:10.1038/modpathol.3800416 · Cited by 49
Proteomic Identification of New Biomarkers and Application in Thyroid Cytology
Torres-Cabala, C. A., Bibbo, M., Panizo-Santos, Á., Barazi, H., Krutzsch, H. C., Roberts, D. D., & Merino, M. J. (2006) · Acta Cytologica · doi:10.1159/000326006 · Cited by 49
Piantelli, M., Iacobelli, S., Almadori, G., Iezzi, M., Tinari, N., Natoli, C., Cadoni, G., Lauriola, L., & Ranelletti, F. O. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.078 · Cited by 48
Serum biomarkers of papillary thyroid cancer
Makki, F. M., Taylor, S. M., Shahnavaz, A., Leslie, A., Gallant, J. W., Douglas, S. E., Teh, E., Trites, J. R. B., Bullock, M. J., Inglis, K. M., et al. (2013) · Journal of Otolaryngology - Head and Neck Surgery · doi:10.1186/1916-0216-42-16 · Cited by 47
Brustmann, H. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31815d060d · Cited by 46
Neder, L., Marie, S. K. N., Carlotti, C. G., Gabbai, A. A., Rosemberg, S., Malheiros, S. M., Siqueira, R. P., Oba‐Shinjo, S. M., Uno, M., de Aguiar, P. H. P., et al. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00083.x · Cited by 46
Carlsson, M. C., Cederfur, C., Schaar, V., Balog, C. I. A., Lepur, A., Touret, F., Salomonsson, E., Deelder, A. M., Fernö, M., Olsson, H. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026560 · Cited by 45
Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients
Iacovazzi, P. A., Notarnicola, M., Caruso, M. G., Guerra, V., Frisullo, S., Altomare, D. F., & Correale, M. (2009) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970902936880 · Cited by 45
Čada, Z., Smetana, K., Lacina, L., Plzáková, Z., Štork, J., Kaltner, H., Russwurm, R., Lensch, M., André, S., & Gabius, H. (2009) · Folia Biologica · doi:10.14712/fb2009055040145 · Cited by 42
Clinical relevance of galectin-1 expression in non-small cell lung cancer patients
Carlini, M. J., Roitman, P. D., Núñez, M., Pallotta, M. G., Boggio, G., Smith, D. E., Salatino, M., Joffé, E. B. D. K., Rabinovich, G. A., & Puricelli, L. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.01.016 · Cited by 41
Localization of galectin-3 in normal and diseased pancreatic tissue
Schaffert, C. S., Pour, P. M., & Chaney, W. G. (1998) · International Journal of Pancreatology · doi:10.1007/bf02787497 · Cited by 40
Vereecken, P., Debray, C., Pétein, M., Awada, A. H., Lalmand, M.-C., Laporte, M., Heule, B. V. D., Verhest, A. P., Pochet, R., & Heenen, M. (2005) · Archives of Dermatological Research · doi:10.1007/s00403-004-0536-6 · Cited by 40
CD24 and Galectin-1 Expressions in Gastric Adenocarcinoma and Clinicopathologic Significance
Bektaş, S., Bahadır, B., Uçan, B. H., & Özdamar, Ş. O. (2010) · Pathology & Oncology Research · doi:10.1007/s12253-010-9248-8 · Cited by 40
Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer
Miwa, H. E., Koba, W. R., Fine, E. J., Giricz, O., Kenny, P. A., & Stanley, P. (2013) · Glycobiology · doi:10.1093/glycob/cwt075 · Cited by 40
p16 inactivation in small-sized lung adenocarcinoma: Its association with poor prognosis
Kawabuchi, B., Moriyama, S., Hironaka, M., Fujii, T., Koike, M., Moriyama, H., Nishimura, Y., Mizuno, S., & Fukayama, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990219)84:1<39::aid-ijc8>3.0.co;2-e · Cited by 39
Juszczyński, P., Rodig, S. J., Ouyang, J., O’Donnell, E. A., Takeyama, K., Mlynarski, W. M., Mycko, K., Szczepański, T., Gaworczyk, A., Krivtsov, A. V., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2765 · Cited by 39
Galectin‐3: differential expression between small‐cell and non‐small‐cell lung cancer
Buttery, R. C., Monaghan, H., Salter, D. M., & Sethi, T. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01815.x · Cited by 39
Ozaki, Y., Kontani, K., Hanaoka, J., Chano, T., Teramoto, K., Tezuka, N., Sawai, S., Fujino, S., Yoshiki, T., Okabe, H., et al. (2002) · Cancer · doi:10.1002/cncr.10899 · Cited by 38
Kondoh, N., Hada, A., Ryo, A., Shuda, M., Arai, M., Matsubara, O., Kimura, F., Wakatsuki, T., & Yamamoto, M. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.6.1575 · Cited by 37
Galectin‐1 supports the survival of CD45RA(−) primary myeloma cells in vitro
Abroun, S., Otsuyama, K., Shamsasenjan, K., Islam, A. B. M. M. K., Amin, J., Iqbal, M. S., Gondo, T., Asaoku, H., & Kawano, M. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07252.x · Cited by 37
Denčić, T. I., Savin, S. B., Cvejic, D. S., Marečko, I., Tatic, S. B., Havelka, M., & Paunovic, I. R. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0838-3 · Cited by 37
Kim, S. J., Lee, S. J., Sung, H. J., Choi, I. K., Choi, C. W., Kim, B. S., Kim, J. S., Yu, W., Hwang, H. S., & Kim, I. S. (2008) · Acta Haematologica · doi:10.1159/000193223 · Cited by 36
Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma
Wollina, U., Graefe, T., Feldrappe, S., André, S., Wasano, K., Kaltner, H., Zick, Y., & Gabius, H. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-001-0304-3 · Cited by 36
Cludts, S., Decaestecker, C., Mahillon, V., et al. (2009) · PubMed · Cited by 36
Increased expression of galectin-1 during the progression of cervical neoplasia
Kohrenhagen, N., Volker, H. U., Kapp, M., Dietl, J., & Kämmerer, U. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00741.x · Cited by 33
Yamaki, S., Fujii, T., Yajima, R., Hirakata, T., Yamaguchi, S., Fujisawa, T., Tsutsumi, S., Asao, T., Yanagita, Y., Iijima, M., et al. (2012) · Surgery Today · doi:10.1007/s00595-012-0378-3 · Cited by 33
Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer
Yang, J., Zhu, L., Cai, Y., Suo, J., & Jin, J. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2494 · Cited by 32
Decreased Galectin-8 Is a Strong Marker for Recurrence in Urothelial Carcinoma of the Bladder
Kramer, M. W., Waalkes, S., Serth, J., Hennenlotter, J., Tezval, H., Stenzl, A., Kuczyk, M. A., & Merseburger, A. S. (2011) · Urologia Internationalis · doi:10.1159/000328439 · Cited by 29
Does phosphorylation of cofilin affect the progression of human bladder cancer?
Chung, H., Kim, B., Jung, S.-H., Won, K., Jiang, X., Lee, C., Lim, S. D., Yang, S., Song, K. H., & Kim, H. S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-45 · Cited by 29
Saffar, H., Sanii, S., Heshmat, R., Haghpanah, V., Larijani, B. A., Rajabiani, A., Azimi, S., & Tavangar, S. M. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpi8ajluz3czln · Cited by 29
Koopmans, S. M., Bot, F., Schouten, H. C., Janssen, J. W. H., & Marion, A. M. W. V. (2012) · Europe PMC (PubMed Central) · Cited by 28
Diagnostic and Prognostic Role of Galectin 3 Expression in Cutaneous Melanoma
Abdou, A. G., Hammam, M. A., El-Farargy, S. M., Farag, A. G. A., Elshafey, E. N., Farouk, S., & Elnaidany, N. F. (2010) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e3181e02f29 · Cited by 28
Schulkens, I. A. E., Heusschen, R., van den Boogaart, V., van Suylen, R. J., Dingemans, A. C., Griffioen, A. W., & Thijssen, V. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107988 · Cited by 28
Self-citationProtein expression patterns associated with advanced stage ovarian cancer
Cortesi, L., Rossi, E. G., Casa, L. D., Barchetti, A., Nicoli, A., Piana, S., Abrate, M., Sala, G. B. L., Federico, M., & Iannone, A. (2011) · Electrophoresis · doi:10.1002/elps.201000654 · Cited by 28
Adhesive and invasive features in gliomas
Tews, D. S. (2000) · Pathology - Research and Practice · doi:10.1016/s0344-0338(00)80122-3 · Cited by 27
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
von Klot, C. A., Kramer, M. W., Peters, I., Hennenlotter, J., Abbas, M., Scherer, R., Herrmann, T. R., Stenzl, A., Kuczyk, M. A., Serth, J., et al. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-15 · Cited by 25
Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Th, T., Swethadri, G. K., Wong, J., Ahmad, T., Jamil, D., Rk, M., Hamdi, M. M., & Abdullah, M. S. (2008) · PubMed · Cited by 23
Liu, T., Chen, C., Tien, H., & Lin, C. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03199.x · Cited by 22
Makino, K., Kawamura, K., Sato, W., Kawamura, N., Fujimoto, T., & Terada, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041049 · Cited by 21
Expression and Functions of Galectin-7 in Human and Murine Melanomas
Biron-Pain, K., Grosset, A., Poirier, F., Gaboury, L. A., & St‐Pierre, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063307 · Cited by 20
Wu, F., Hu, N., Li, Y., et al. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0075-7 · Cited by 19
Galectins in Regulation of Apoptosis
Liu, F., Yang, R., Saegusa, J., Chen, H., & Hsu, D. K. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7877-6_22 · Cited by 18
Zhong, L., Wei, K., Yang, X. Y., Pan, H., Ye, D., Wang, L., & Zhang, Z. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0810-2 · Cited by 17
Hann, A., Gruner, A., Chen, Y., Gress, T. M., & Buchholz, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020859 · Cited by 17
Galectin-8 Expression in Laryngeal Squamous Cell Carcinoma
Dong, G.-W., Kim, J., Park, J. H., Choi, J. Y., Cho, S. I., & Lim, S. (2009) · Clinical and Experimental Otorhinolaryngology · doi:10.3342/ceo.2009.2.1.13 · Cited by 15
Weissenbacher, T. M., Kühn, C., Mayr, D. C., et al. (2011) · PubMed · Cited by 12
Cited by
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Huinen, Z. R., Huijbers, E. J. M., van Beijnum, J. R., Nowak-Sliwinska, P., & Griffioen, A. W. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00496-y · Cited by 395
Self-citationBiomarkers in Cancer Detection, Diagnosis, and Prognosis
Das, S., Dey, M. K., Devireddy, R., & Gartia, M. R. (2023) · Sensors · doi:10.3390/s24010037 · Cited by 383
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Emerging Opportunities and Challenges in Cancer Immunotherapy
Whiteside, T. L., Demaria, S., Rodriguez-Ruiz, M. E., Zarour, H. M., & Melero, I. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0049 · Cited by 317
Metadata
- Authors
- Thijssen, V. L., Heusschen, R., Caers, J., & Griffioen, A. W.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 1855
- Issue
- 2
- Pages
- 235-247
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2055040332
- Cited by
- 279
- References
- 161
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.